Department of Vascular and Endovascular Surgery, Paracelsus Medical University Nuremberg, General Hospital Nuremberg, Germany.
Department of Vascular and Endovascular Surgery, Paracelsus Medical University Nuremberg, General Hospital Nuremberg, Germany.
Eur J Vasc Endovasc Surg. 2020 Jul;60(1):44-48. doi: 10.1016/j.ejvs.2020.03.003. Epub 2020 Mar 31.
Treatment of complex aortic pathologies with customised fenestrated/branched stent grafts (F/BEVAR) is associated with a longer waiting time to the procedure. This study aimed to investigate the prevalence of aneurysm rupture and mortality during the waiting time for a fenestrated/branched stent graft in a single centre.
All patients with a pararenal (PAA), thoraco-abdominal (TAAA), or aortic arch aneurysm planned to be treated with a customised F/BEVAR between January 2010 and December 2018 were included. Patients planned for F/BEVAR who in the end did not undergo the procedure were analysed.
906 patients were planned to undergo F/BEVAR during the study period. Of those, 862 (95.1%) underwent the procedure as planned (FEVAR for PAA; n = 494, F/BEVAR for TAAA; n = 348, F/BEVAR for arch aneurysm; n = 20). In 44 (4.9%) patients, the procedure was cancelled. Thirty-seven (4.1%) patients died before the procedure, four (0.4%) patients turned down the procedure, two (0.2%) were cancelled because of worsened general condition, and one (0.1%) ruptured but underwent emergency open repair in another institution. Causes of death during the waiting time were: aneurysm rupture, n = 15 (1.7%); cardiac, n = 7 (0.8%); stroke, n = 3 (0.3%); gastrointestinal, n = 3 (0.3%); death after complete arch debranching, n = 2 (0.2%); infection, n = 2 (0.2%); death after transcatheter aortic valve implantation, n = 1 (0.1%); death after urological surgery, n = 1 (0.1%); unknown, n = 3 (0.3%). Aneurysm diameter was larger in patients who died of aneurysm rupture compared with patients who died as a result of other causes (79.2 ± 13 mm vs. 66.7 ± 12 mm, respectively, p = .005).
Aneurysm rupture during the waiting time for F/BEVAR can occur but is rare. Patients with a larger aneurysm diameter may be at higher risk of rupture. Measures to reduce the risk of rupture during the waiting time might include the use of off the shelf devices for larger aneurysms, quicker measurement and graft plan order processes, and quicker graft construction and delivery.
使用定制的开窗/分支支架移植物(F/BEVAR)治疗复杂的主动脉病变与手术等待时间延长有关。本研究旨在调查单一中心接受开窗/分支支架移植物治疗的患者在等待期间发生动脉瘤破裂和死亡的情况。
纳入 2010 年 1 月至 2018 年 12 月期间计划使用定制 F/BEVAR 治疗的肾周(PAA)、胸腹(TAAA)或主动脉弓动脉瘤患者。分析最终未行 F/BEVAR 治疗的患者。
研究期间计划接受 F/BEVAR 治疗的患者为 906 例。其中 862 例(95.1%)按计划接受了治疗(PAA 行 FEVAR:n=494 例;TAAA 行 F/BEVAR:n=348 例;弓部动脉瘤行 F/BEVAR:n=20 例)。44 例(4.9%)患者取消了手术。37 例(4.1%)患者在手术前死亡,4 例(0.4%)患者拒绝手术,2 例(0.2%)因一般状况恶化而取消手术,1 例(0.1%)破裂,但在另一家机构接受了急诊开放修复。等待期间的死亡原因包括:动脉瘤破裂,n=15(1.7%);心脏,n=7(0.8%);中风,n=3(0.3%);胃肠道,n=3(0.3%);全主动脉弓去分支术后死亡,n=2(0.2%);感染,n=2(0.2%);经导管主动脉瓣植入术后死亡,n=1(0.1%);泌尿外科手术后死亡,n=1(0.1%);原因不明,n=3(0.3%)。与因其他原因死亡的患者相比,死于动脉瘤破裂的患者的动脉瘤直径更大(分别为 79.2±13mm 和 66.7±12mm,p=0.005)。
F/BEVAR 治疗等待期间可能发生动脉瘤破裂,但较为罕见。动脉瘤直径较大的患者破裂风险可能更高。减少等待期间破裂风险的措施可能包括使用更大直径动脉瘤的即用型设备、更快的测量和移植物计划流程、以及更快的移植物构建和交付。